Stine D. Henriksen
Aalborg, 9000, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Cell-Free DNA Hypermethylation in Patients with Acute Pancreatitis.
Journal: International journal of molecular sciences
Published: October 01, 2025
A novel prediction model of mortality in chronic pancreatitis using clinical characteristics and gene promoter hypermethylation status.
Journal: Scandinavian journal of gastroenterology
Published: September 03, 2025
Diagnostic yield of second-line aetiological workup in patients with presumed idiopathic acute pancreatitis: a retrospective cohort study.
Journal: Scandinavian journal of gastroenterology
Published: March 31, 2025
Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma.
Journal: Frontiers in oncology
Published: January 30, 2025
Prediction of pancreatic cancer risk in patients with new-onset diabetes using a machine learning approach based on routine biochemical parameters.
Journal: Computer methods and programs in biomedicine
Published: October 16, 2023
Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma.
Journal: Frontiers in oncology
Published: April 24, 2023
Risk of pancreatic cancer in people with new-onset diabetes: A Danish nationwide population-based cohort study.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: April 12, 2023
Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: February 02, 2023
Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma.
Journal: Cancers
Published: September 15, 2021
Cell-free DNA promoter hypermethylation as a diagnostic marker for pancreatic ductal adenocarcinoma - An external validation study.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: January 05, 2021
Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
Journal: Scandinavian journal of gastroenterology
Published: March 26, 2019
Last Updated: 09/26/2026